UK, Sweden Test Differing Antibiotic Market Models
But Both Seek Reward Mechanisms That Assure National Antibiotic Supplies
Executive Summary
Sweden and the UK are conducting differing ‘develop and test’ programs to assess so-called ‘pull’ incentives in which an antibiotics innovator will be paid an annual fee in return for an access guarantee for anti-infectives. The projects have drawn keen attention from other countries.
You may also be interested in...
Global AMR R&D Hub Launches Dynamic Data Dashboard
The Global AMR R&D Hub’s newly launched Dynamic Dashboard aims to be “a comprehensive knowledge center for AMR R&D and market reforms,” its head tells Scrip.
Lord O’Neill Blames Governments And Pharma For Faltering AMR Progress
Three years after completion of his high-profile AMR Review, Jim O’Neill warns that global progress on antimicrobial resistance has slowed dangerously.
Manipulating Metabolism: Lilly Links With UK Biotech Sitryx
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.
Need a specific report? 1000+ reports available
Buy Reports
| Table |
|---|